YC Companies/Winter 2021/Forcyte Biotechnologies
Forcyte Biotechnologies logo

Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

Winter 2021Healthcare / Healthcare -> DiagnosticsLos Angeles, CA, USA5 employees
Drug discovery

About

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Founders (2)

Ivan Pushkarsky
Founder
Dino Di Carlo
Founder

Details

Status
Active
Stage
Early
Team Size
5
Regions
United States of America, America / Canada